Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in mice

Show simple item record

dc.contributor.author Verma, Rahul Kumar
dc.contributor.author Germishuizen, Willem Andreas
dc.contributor.author Motheo, M.P. (Mamofalali Portia)
dc.contributor.author Agrawal, Atul Kumar
dc.contributor.author Singh, Amit Kumar
dc.contributor.author Mohan, Mradul
dc.contributor.author Gupta, Pushpa
dc.contributor.author Gupta, Umesh Datta
dc.contributor.author Cholo, Moloko C.
dc.contributor.author Anderson, Ronald
dc.contributor.author Fouche, P. Bernard
dc.contributor.author Misra, Amit
dc.date.accessioned 2014-04-10T09:13:00Z
dc.date.available 2014-04-10T09:13:00Z
dc.date.issued 2013-02
dc.description.abstract Inhalable clofazimine-containing dry powder microparticles (CFM-DPI) and native clofazimine (CFM) were evaluated for activity against Mycobacterium tuberculosis in human monocyte-derived macrophage cultures and in mice infected with a low-dose aerosol. Both formulations resulted in 99% killing at 2.5 g/ml in vitro. In mice, 480 g and 720 g CFM-DPI inhaled twice per week over 4 weeks reduced numbers of CFU in the lung by as much as log10 2.6; 500 g oral CFM achieved a log10 0.7 reduction. en_US
dc.description.librarian am2014 en_US
dc.description.librarian ay2014
dc.description.sponsorship The Indian work was funded by a grant from CSIR, India (NWP0035). R.K.V., A.K.S., and A.K.A. received research fellowships from CSIR, India, and M.M. received one from ICMR, India. The South African work was supported by The South African Medical Research Council (M.P.M., M.C., R.A.) and a K-RITH collaborative grant (Howard Hughes Medical Institute and the University of KwaZulu-Natal, to P.B.F. and W.A.G.). en_US
dc.description.uri http://aac.asm.org/ en_US
dc.identifier.citation Verma, RK, Germishuizen, WA, Motheo, MP, Agrawal, AK, Singh, AK, Mohan, M, Gupta, P, Gupta, UD, Cholo, M, Anderson, R, Fourie, PB & Misra, A 2013, 'Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in mice', Antimicrobial Agents and Chemotherapy , vol. 57, no. 2, pp. 1050-1052. en_US
dc.identifier.issn 0066-4804 (print)
dc.identifier.issn 1098-6596 (online)
dc.identifier.other 10.1128/AAC.01897-12
dc.identifier.uri http://hdl.handle.net/2263/39634
dc.language.iso en en_US
dc.publisher American Society for Microbiology en_US
dc.rights © 2013, American Society for Microbiology. All Rights Reserved. en_US
dc.subject Microparticles en_US
dc.subject Clofazimine en_US
dc.subject Treatment en_US
dc.subject Mice en_US
dc.subject.lcsh Tuberculosis -- Treatment -- Research en
dc.title Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in mice en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record